Glenmark

- Read more about Glenmark Cholesterol-Lowering Drug Ezetimibe receive US Regulator's Nod
Glenmark Pharmaceuticals, has received approval from the US Food and Drug Administration (US FDA) for its cholesterol-lowering drug Ezetimibe. Ezetimibe is the generic version of Merck-Schering Plough's cholesterol-lowering drug with the product name Zetia.
- Read more about Glenmark receive US FDA approval for generic Dovonex cream, 0.005%
Glenmark Pharmaceuticals Inc., USA (Glenmark) get final approval by the United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex cream, 0.005 per cent of Leo Pharma A/S. Glenmark strategy to start to shipping of calcipotriene cream, 0.005 per cent immediately.
- Read more about Glenmark receive USFDA approval to sell Rufinamide
Glenmark Pharmaceuticals granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome.
- Read more about Glenmark Pharma gets tentative ANDA approval from US FDA for rufinamide tablets USP
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received US FDA tentative ANDA approval for its rufinamide tablets USP, 200 mg and 400 mg.
- Read more about Glenmark receives US FDA approval for norethindrone acetate and ethinyl estradiol tablets USP
Glenmark Generics Inc. USA, a subsidiary of Glenmark Generics, has received the final approval from the United States Food and Drug Administration (USFDA) for sale of drugs meant to prevent post-menopause osteoporosis.USFDA granted Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1 mg/5 mcg.
13 April 2012

Opening in Glenmark Pharmaceuticals as Manager - Business Planning

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
20 March 2012

Work as Asst. Manager QA - Loan Licence in Glenmark Pharma

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
7 January 2012

Immediate Walk in interview in Glenmark Pharma | Work in Production and Warehouse departments

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
12 September 2011

Post for Senior Research Officer in Glenmark Pharma

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
30 August 2011

Post for a Research Associate - QA at Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.